Galectins

Galectin-3 antagonist 1 (compound 15) is a potent and selective Galectin-3 ( Gal-3 ) antagonist with K d value of 5.3 μM. Meanwhile, Galectin-3 antagonist 1 binds to various Galectin with K d values of 250 μM (Gal-4N), 18 μM (Gal-4C), 450 μM

Galectin-3 antagonist 1 (compound 15) is a potent and selective Galectin-3 ( Gal-3 ) antagonist with K d value of 5.3 μM. Meanwhile, Galectin-3 antagonist 1 binds to various Galectin with K d values of 250 μM (Gal-4N), 18 μM (Gal-4C), 450 μM

Galectin-3 antagonist 1 (compound 15) is a potent and selective Galectin-3 ( Gal-3 ) antagonist with K d value of 5.3 μM. Meanwhile, Galectin-3 antagonist 1 binds to various Galectin with K d values of 250 μM (Gal-4N), 18 μM (Gal-4C), 450 μM

GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a K d of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic modelIn VitroTreatment with

GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a K d of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic modelIn VitroTreatment with

GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a K d of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic modelIn VitroTreatment with

GB1107 is a potent, selective, orally active inhibitor of Galectin-3 (Gal-3) with a K d of 37 nM for human Galectin-3. GB1107 reduces human and mouse lung adenocarcinoma growth and blocks metastasis in the syngeneic modelIn VitroTreatment with

Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitorForm:SolidIC50&amp Target:Gal-3

Selvigaltin (GB1211) is an orally available galectin-3 (Gal-3) inhibitorForm:SolidIC50&amp Target:Gal-3